Echocardiographic Findings and NT-proBNP Level in Type-2 Diabetic Patients With and Without Ischemic Heart Disease

The aim of this study was to determine whether there are differences in echocardiographic findings or in the level of a biochemical marker (ie, N-terminal probrain natriuretic peptide [NT-proBNP]) between controls and type-2 diabetic patients with or without ischemic heart disease. Echocardiography...

Full description

Saved in:
Bibliographic Details
Published in:Revista española de cardiología (English ed.) 2009-10, Vol.62 (10), p.1184-1188
Main Authors: Rodríguez, Sara Castaño, Coma-Canella, Isabel, Salazar, Begoña López, Cosials, Joaquín Barba
Format: Article
Language:English
Subjects:
BNP
Cardiopatía isquémica
Diabetic cardiomyopathy
Diastolic dysfunction
Disfunción diastólica
Ischemic heart disease
Miocardiopatía diabética
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The aim of this study was to determine whether there are differences in echocardiographic findings or in the level of a biochemical marker (ie, N-terminal probrain natriuretic peptide [NT-proBNP]) between controls and type-2 diabetic patients with or without ischemic heart disease. Echocardiography was used to assess left ventricular function and morphology. In addition, the plasma NT-proBNP concentration was measured. The prevalence of diastolic dysfunction was greater in diabetics without ischemic heart disease than in controls (88% vs 74%, respectively; P
ISSN:1885-5857
1885-5857
DOI:10.1016/S1885-5857(09)73334-1